First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes.
dc.contributor.author | Chiara Garassino, Marina | |
dc.contributor.author | Chen, Yuanbin | |
dc.contributor.author | Paz-Ares, Luis G. | |
dc.contributor.author | Dvorkin, Mikhail | |
dc.contributor.author | Trukhin, Dmytro | |
dc.contributor.author | Reinmuth, Niels | |
dc.contributor.author | Statsenko, Galina | |
dc.contributor.author | Voitko, Oleksandr | |
dc.contributor.author | Hochmair, Maximilian | |
dc.contributor.author | Ozguroglu, Mustafa | |
dc.contributor.author | Verderame, Francesco | |
dc.contributor.author | Havel, Libor | |
dc.contributor.author | Losonczy, Gyorgy | |
dc.contributor.author | Conev, Nikolay | |
dc.contributor.author | Hotta, Katsuyuki | |
dc.contributor.author | Ji, Jun Ho | |
dc.contributor.author | Broadhurst, Helen | |
dc.contributor.author | Byrne, Natalie | |
dc.contributor.author | Thiyagarajah, Piruntha | |
dc.contributor.author | Wade Goldman, Jonathan | |
dc.date.accessioned | 2021-03-02T18:31:16Z | |
dc.date.available | 2021-03-02T18:31:16Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Chen Y., Paz-Ares L. G. , Dvorkin M., Trukhin D., Reinmuth N., Chiara Garassino M., Statsenko G., Voitko O., Hochmair M., Ozguroglu M., et al., "First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes.", JOURNAL OF CLINICAL ONCOLOGY, cilt.38, 2020 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.other | av_ed555aa7-cf18-43cf-ace7-9099cd012b62 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/5077 | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Klinik Tıp | |
dc.subject | Onkoloji | |
dc.subject | ONKOLOJİ | |
dc.title | First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes. | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF CLINICAL ONCOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 38 | |
dc.identifier.issue | 15 | |
dc.contributor.firstauthorID | 2281671 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Makale [92796]